Vaccine trial continues | THE DAILY TRIBUNE | KINGDOM OF BAHRAIN

Vaccine trial continues

Khaled Al-Maskati, Member of the Shura Council and Brigadier Doctor Abdullah Hassan Darwish, Technical Assistant to the Commander of the Royal Medical Services, volunteered for the third phase clinical trials of the China-based Sinopharm’s Covid-19 vaccine candidate.

The study of the inactivated vaccine candidate assesses its effectiveness in antibody generation and the acquired protection against the virus.

In Bahrain, the trial involves up to 6,000 volunteers aged more than 18 years.
The trial in UAE is being conducted by Sinopharm’s China National Biotec Group (CNBG) in alliance with the Abu Dhabi Government and artificial intelligence firm G42 Healthcare.